IN2013MN01005A - - Google Patents

Download PDF

Info

Publication number
IN2013MN01005A
IN2013MN01005A IN1005MUN2013A IN2013MN01005A IN 2013MN01005 A IN2013MN01005 A IN 2013MN01005A IN 1005MUN2013 A IN1005MUN2013 A IN 1005MUN2013A IN 2013MN01005 A IN2013MN01005 A IN 2013MN01005A
Authority
IN
India
Prior art keywords
sub
modifying
totipotent
differentiated
label
Prior art date
Application number
Inventor
Chunhua Zhao
Jing Li
Hongling Li
Jianhe Chen
Qin Han
Kanghua Li
Jing Wang
Original Assignee
Beijing Jingyuan Yaneng Biotechnologies Co; Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Jingyuan Yaneng Biotechnologies Co; Ltd filed Critical Beijing Jingyuan Yaneng Biotechnologies Co; Ltd
Publication of IN2013MN01005A publication Critical patent/IN2013MN01005A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Provided are a sub totipotent stem cell product and apparent hereditary modifying label thereof a method for inducing the generation of the sub totipotent stem cell product and identification for the apparent hereditary modifying label of the differentiated potential of stem cells. Also provided is a use of a histone modifying state of a sub totipotent gene and/or differentiated related gene to predict the apparent hereditary modifying label of the differentiated potential of stem cells.
IN1005MUN2013 2010-12-09 2011-12-02 IN2013MN01005A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2010/079608 WO2012075636A1 (en) 2010-12-09 2010-12-09 Tags of epigenetic modification for predicting differential potential of stem cells
PCT/CN2011/083380 WO2012075912A1 (en) 2010-12-09 2011-12-02 Sub-totipotent stem cell product and apparent hereditary modifying label thereof

Publications (1)

Publication Number Publication Date
IN2013MN01005A true IN2013MN01005A (en) 2015-09-25

Family

ID=46206539

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1005MUN2013 IN2013MN01005A (en) 2010-12-09 2011-12-02

Country Status (6)

Country Link
US (1) US9523074B2 (en)
EP (1) EP2636732B1 (en)
AU (1) AU2011341213B2 (en)
CA (1) CA2820395C (en)
IN (1) IN2013MN01005A (en)
WO (2) WO2012075636A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103667190A (en) * 2012-09-07 2014-03-26 上海吉凯基因化学技术有限公司 Method for forming nerve cells by induction and composition
CN103865873B (en) * 2012-12-12 2017-04-05 中国医学科学院基础医学研究所 The allochthon of Subaerial blue green algae secretion and its application
CN110499284A (en) * 2018-05-17 2019-11-26 西安组织工程与再生医学研究所 Wnt signal path activator is preparing the application in therapeutic gene ALPL knock-out mice tooth hard tissue mineralization anomaly product
CN120404500B (en) * 2025-03-18 2026-03-17 君和正源(上海)生物医药科技有限公司 An analytical method for detecting the H3K27me3 level of various immune cell populations in human whole blood using flow cytometry.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056738B2 (en) * 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
JP2004248505A (en) * 2001-09-21 2004-09-09 Norio Nakatsuji Undifferentiated fusion cell of somatic cell derived from es cell deficient in part or all of transplantation antigen and method for producing the same
CN1778905B (en) * 2004-11-22 2010-05-05 赵春华 Separating culture and use for fatty mesenchymal dry cell
GB0601538D0 (en) * 2006-01-26 2006-03-08 Univ Birmingham Epigenetic analysis
WO2009030092A1 (en) * 2007-09-05 2009-03-12 Institute Of Basic Medical Sciences Chinese Academy Of Medical Sciences Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on a large scale, primary mesenchymal stem cells obtained by the method, the uses thereof
US8524498B2 (en) * 2009-05-29 2013-09-03 The General Hospital Corporation Methods and compositions for homologous recombination in human cells

Also Published As

Publication number Publication date
CA2820395A1 (en) 2012-06-14
EP2636732A1 (en) 2013-09-11
AU2011341213B2 (en) 2016-08-18
EP2636732A4 (en) 2014-05-07
US20140287930A1 (en) 2014-09-25
AU2011341213A1 (en) 2013-07-11
CA2820395C (en) 2017-03-07
EP2636732B1 (en) 2018-05-30
WO2012075636A1 (en) 2012-06-14
US9523074B2 (en) 2016-12-20
WO2012075912A9 (en) 2013-09-06
WO2012075912A1 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
IL288185B1 (en) Novel methods and culture media for culturing pluripotent stem cells
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
ZA201006683B (en) Combined chemical and genetic approaches for generation of induced pluripotent stem cells
IL267629A (en) Method of culturing eukaryotic cells
IN2014DN10996A (en)
IL214529A0 (en) Bioreactor for the cultivation of mammalian cells and methods of use thereof
IL216902A0 (en) Methods for culturing stem and progentitor cells
IL252045B (en) An isolated nucleic acid, an expression vector and a cultured cell comprising the isolated nucleic acid
WO2010111409A3 (en) Pluripotent stem cells
SG10201602507UA (en) Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor
SG196784A1 (en) Stem cell cultures
HUE062459T2 (en) Culture medium for epithelial stem cells and organoids containing epithelial stem cells
IL213582A0 (en) Generation and maintenance of stem cells
IL221481A0 (en) Method of efficiently establishing induced pluripotent stem cells
EP2499241B8 (en) Methods of generating neural stem cells
MX2010000348A (en) Single pluripotent stem cell culture.
IN2012DN00852A (en)
IN2012DN00581A (en)
EP2513297A4 (en) Materials and methods for generating pluripotent stem cells
IN2013MN01005A (en)
IL218111A0 (en) Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells
WO2012046065A3 (en) Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a*
WO2010105257A3 (en) Generation of mouse induced pluripotent stem cells bytransient expression of a single non- viral polycistronic vector
RU2012135981A (en) METHOD FOR REPROGRAMMING PRIMARY MELANOMA TUMOR CELLS IN PLURIPOTENT STEM CELLS
HK1176639A (en) Materials and methods for generating pluripotent stem cells